Valuation: COMPASS Pathways plc

Market Cap 1.84B 1.61B 1.48B 1.38B 2.61B 175B 2.65B 17.77B 6.89B 85.89B 6.91B 6.76B 296B P/E 2026 *
-13.2x
P/E 2027 * -9.59x
Enterprise Value 1.42B 1.24B 1.14B 1.06B 2.01B 135B 2.04B 13.67B 5.3B 66.08B 5.31B 5.2B 228B EV / Sales 2026 *
-
EV / Sales 2027 * 22.2x
Free-Float
25.07%
Yield 2026 *
-
Yield 2027 * -
1 day+2.48%
1 week+0.29%
Current month-3.75%
1 month+2.18%
3 months+135.23%
6 months+107.94%
Current year+97.39%
1 week 12.78
Extreme 12.7842
15.4
1 month 10.72
Extreme 10.724
15.4
Current year 4.88
Extreme 4.88
15.4
1 year 3.24
Extreme 3.24
15.4
3 years 2.25
Extreme 2.25
15.4
5 years 2.25
Extreme 2.25
49.52
10 years 2.25
Extreme 2.25
61.69
Manager TitleAgeSince
Chief Executive Officer 61 2022-07-31
Director of Finance/CFO 54 2024-02-29
Chief Tech/Sci/R&D Officer 66 2024-04-30
Director TitleAgeSince
Chairman 74 2024-03-28
Director/Board Member 69 2020-03-31
Director/Board Member 66 2021-02-28
Date Insider Type Main position Quantity % Market Cap.
05-26Free

Director

21,110 0.0220%
05-26Free

Director

21,110 0.0220%
05-26Free

Director

21,110 0.0220%
Change 5-day change 1-year change 3-year change Capi.($)
+2.48%+0.29%+302.96%+64.49% 1.79B
+0.36%+5.10%+1.04%+5.85% 48.62B
+0.92%+6.21%+408.85%+607.44% 39.86B
+1.89%+11.06%+25.75%-7.89% 33.91B
+2.38%+8.10%+21.83%+66.94% 32.32B
+1.20%+2.02%+9.79%+32.43% 24.73B
+2.51%+4.94% - - 16.63B
+2.58%+7.24%+71.03%+132.17% 15.52B
+0.99%+1.26%+13.98%+18.88% 13.63B
-1.14%+7.52%+14.75%-30.83% 13.41B
Average +1.42%+6.49%+96.66%+98.83% 24.04B
Weighted average by Cap. +1.29%+6.99%+90.27%+130.51%

Financials

2026 *2027 *
Net sales - 60.17M 52.58M 48.28M 45.03M 85.36M 5.73B 86.8M 581M 225M 2.81B 226M 221M 9.68B
Net income -100M -87.67M -80.51M -75.08M -142M -9.55B -145M -969M -376M -4.69B -377M -369M -16.14B -197M -172M -158M -148M -280M -18.77B -284M -1.9B -738M -9.21B -740M -724M -31.72B
Net Debt -424M -371M -340M -317M -602M -40.38B -612M -4.1B -1.59B -19.8B -1.59B -1.56B -68.24B -505M -442M -406M -378M -717M -48.12B -729M -4.88B -1.89B -23.6B -1.9B -1.86B -81.33B
Logo COMPASS Pathways plc
Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in treating mental health conditions focused on rapid and durable responses through the development of its investigational COMP360 psilocybin treatment. COMP360 is its psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. It commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. It also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.
Employees
156
Date Price Change Volume
26-07-02 US$13.62 +2.48% 4,103,044
26-07-01 US$13.29 -6.08% 4,743,546
26-06-30 US$14.15 -6.10% 3,467,572
26-06-29 US$15.07 +1.69% 3,601,557
26-06-26 US$14.82 +9.13% 5,486,747
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
13.63USD
Average target price
22.33USD
Spread / Average Target
+63.85%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CMPS Stock